Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?

Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?

The global range and high fatality rate of the newest human coronavirus (HCoV) pandemic has made SARS-CoV-2 the focus of the scientific world. Next-generation sequencing of the viral genome and a phylogenetic analysis have shown the high homology of SARS-CoV-2 to other HCoVs that have led to local e...

Full description

Bibliographic Details
Main Authors: Emilia Sinderewicz, Wioleta Czelejewska, Katarzyna Jezierska-Wozniak, Joanna Staszkiewicz-Chodor, Wojciech Maksymowicz
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pathogens
Subjects:
COVID-19
immune system
MERS
SARS
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-0817/9/9/739

Similar Items

Similar Items